期刊文献+

化疗并后程加速超分割放疗中晚期食管癌 被引量:3

Concurent chemotherapy combined with late course accelerated hyperfractionated radiotherapy for advanced esophageal carcinoma
原文传递
导出
摘要 目的 观察同期化疗并后程加速超分割放疗 (后超组 )和同期化疗并常规分割放疗治疗食管癌 (常规组 )的疗效和毒性 ,寻找更有效的局部控制率和降低远处转移率并提高生存率的治疗方法。方法 选择病变长度≤ 12cm、无远处转移证据的中晚期食管癌分后超组和常规组各 4 0例。两组化疗方案相同。后超组放疗第 1~ 2 8天 ,为常规分割放疗 ,缩野后行加速超分割放疗 ,总剂量为 6 7Gy 38次 ,共 4 2d。常规组放疗为全程常规分割放疗 ,总剂量为 70Gy 35次 ,共 4 9d。结果近期疗效后超组 :Ⅰ +Ⅱ级 31例占 77 5 % ,Ⅲ +Ⅳ级 9例占 2 2 5 % ,常规组 :Ⅰ +Ⅱ级 2 2例占5 5 0 % ,Ⅲ +Ⅳ级 18例占 4 5 0 % (P <0 0 5 )。后超组和常规组 1,2年局部控制率分别为 77 14 %、5 1 86 %和 5 5 2 1%、31 2 8% (P =0 0 4 9) ;后超组和常规组 1,2年生存率分别为 72 2 2 %、4 8 6 4 %和5 4 0 9%、2 7 33% (P =0 0 4 1)。急性放射性食管炎后超组明显重于常规组 ,且持续时间长。白细胞下降、胃肠道不良反应及放射性肺炎两组比较 ,其差异无显著性 (P >0 0 5 )。结论  (1)同期化疗并后程加速超分割放疗的放射性食管炎虽有所增加 ,但多数患者能耐受 ;(2 ) Objective In order to explore a more effective treatment regiment to improve the local control and the survival rate while reducing distant metastases.This study was aimed to evaluate the effect and toxicity of late accelerated hyperfractionated radiotherapy(LAHF)versus conventional radiotherapy(CF)for patients with advanced esophageal carcinoma.Both groups received concomitant chemotherapy. Methods Eighty patients with advanced esophageal squamous cell carcinoma were included.The eligible criteria included the tumor mass being less than 12 cm in length,and without distant metastases.The patients were randomized into LAHF and CF group.The general conditions of the patients of these two groups did not have statistical significant difference.For the CF group,70 Gy were given in 35 fractions over 49 days,whereas for the LAHF group,radiotherapy was divided into two phases:40 Gy in the first phase with fraction dose 2 Gy per day,27 Gy were given during the second phase with 1.5 Gy per fraction and two fractions a day.The total dose in LAHF group was 67 Gy in 38 fractions over 42 days.The chemotherapy were delivered concurrently with FUDR 500 mg/m +2 and cisplatin 20 mg/m +2 given twice weekly for 3 weeks. Results Thirty-one cases of 1 to 2 grade (77.5%) and 9 cases of 3 to 4 grade (22.5%)in LAHF group showed short-term effect,which was superior to that 22 cases of 1 to 2 grade (55.0%) and 18 cases of 3 to 4 grade (45.0%) in CF group did ( P <0.05).The 1- and 2-year local control rate were 77.14%,51.86% in LAHF group and 55.21%,31.28% in CF group,respectively( P =0.049).The 1- and 2-year survival rate were 72.22%,48.64% in LAHF group and 54.09%,27.33% in CF group,respectively( P =0.041).The acute esophagitis was more severe and lasted longer in LAHF than that in CF group.Leucocytopenia,gastrointestinal tract side-reaction acute pneumonitis, and bone marrow depression induced by radiation were not significant difference between these two groups. Conclusion Combined with concomitant chemotherapy,short-term effect,local control and survival rates in LAHF group were better than that in CF group.The incidence of acute esophageal mucositis was relatively higher in LAHF group,but can be tolerated by most patients. ;
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2003年第5期343-345,共3页 Chinese Journal of Radiological Medicine and Protection
关键词 化疗 后程加速超分割放疗 中晚期 食管癌 Esophageal neoplasm Radiotherapy Chemotherapy Late accelerated hyperfractional radiotherapy Toxicity of treatment
  • 引文网络
  • 相关文献

参考文献6

  • 1邹长林,胡美龙.后程加速超分割放射治疗食管癌疗效荟萃分析[J].中华放射肿瘤学杂志,2001,10(1):18-20. 被引量:33
  • 2韩企夏.食管癌[A].见:汤钊猷主编.现代肿瘤学:第2版[C].上海:上海医科大学出版社,2000.658~694.
  • 3Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01 ). Radiation Therapy Oncology Group. JAMA, 1999. 281 :1623-1627.
  • 4AI-Sarraf M, Martz K, Herskovic A, et al. Progress reportt of combined ehemoradiotherapy versus radiotherapy alone in patients with esophageal cancer:an intergroup study. J Clin Oneol, 1997,15:277-284.
  • 5Meta-Analysis Group In Cancer. Reappraisal of hepatic arterial in fusion inthe treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst, 1996,88 : 252-258.
  • 6Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica. 1988, 27: 131-146.

二级参考文献5

共引文献50

同被引文献15

引证文献3

二级引证文献28

;
使用帮助 返回顶部